The epidemiology of irritable bowel syndrome (IBS) in Europe and North America was analyzed from published material. The percentage of the population of Western civilisation with IBS symptoms is between 10 and 15% in most studies. The proportion of a Western population visiting a doctor for IBS symptoms is around 5%. The prevalence of IBS and the proportion of consulters do not seem to depend on age in an adult population. The female-to-male ratio of IBS in the population is close to 2. It is higher in IBS consulters in primary care and may be as high as 3 or 4 in tertiary referral centers. At least in patients from these centers, the number of physician visits and colonoscopies is considerable. Most of the consulters get a drug prescription.

Journal Section:
Working Team Report
Keywords:
Irritable bowel syndrome, Epidemiology, Prevalence, Reporter, Consulter
1.
Manning AP, Thompson WG, Heaton KW, Morris AF: Towards positive diagnosis of the irritable bowel. Br Med J 1978;ii:653–654.
2.
Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G: Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992;5:75–91.
3.
Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA: Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl II):43–47.
4.
Metman EH, Jougla E, Maguin P, Diaz-Valdes R, Minvielle D: Morbidité digestive diagnostiquée chez l’adulte. Résultats d’une enquête épidémiologique. Gastroentérol Clin Biol 1980;4:858–869.
5.
Frexinos J, Denis P, Allemand H, Allouche S, Los F, Bonnelye G: Etude descriptive des symptomes fonctionnels digestifs dans la population générale française. Gastroentérol Clin Biol 1998;22:85–791.
6.
Bommelear G, Rouch M, Dapoigny M, Pais D, Loisy P, Gualino M, Tournut R: Epidémiologie des troubles fonctionnels intestinaux dans une population apparemment saine. Gastroentérol Clin Biol 1986;10:7–12.
7.
Bommelaer G, Dorval E, Denis P, Czernichow P, Frexinos J, Pelc A, Slama A, El Hasnoui A: Prevalence of irritable bowel syndrome according to the Rome criteria in the French population. Gastroenterology 2000;118(suppl 2): A3.950.
8.
Kennedy TM, Jones RH, Hungin APS, O’Flanagan H, Kelly P: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyperresponsiveness in the general population. Gut 1998;43:770–774.
[PubMed]
9.
Heaton KW, O’Donnell LJD, Braddon FEM, Mountford RA, Hughes AO, Cripps PJ: Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 1992;102:1962–1667.
[PubMed]
10.
Jones R, Lydeard S: Irritable bowel syndrome in the general population. Br Med J 1992;304:87–90.
11.
Thompson WG, Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology 1980;79:283–288.
[PubMed]
12.
Ruigomez A, Wallander MA, Johansson S, García Rodriguez LA: One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther 1999;13:1097–1102.
[PubMed]
13.
Thompson GW, Heaton KW, Smyth GT, Smyth C: Irritable bowel syndrome: The view from general practice. Eur J Gastroenterol Hepatol 1997;9:689–692.
[PubMed]
14.
Thompson GW, Heaton KW, Smyth GT, Smyth C: Irritable bowel syndrome in general practice. Prevalence, characteristics, and referral. Gut 2000;46:78–82.
[PubMed]
https://doi.org/10.1136/gut.46.1.78
15.
Prior A, Wilson K, Whorwell PJ, Faragher EB: Irritable bowel syndrome in the gynecologic clinic. Dig Dis Sci 1989;34:1820–1824.
[PubMed]
16.
Holtmann G, Goebell H, Talley NJ: Dyspepsia in consulters and nonconsulters: Prevalence, health-care-seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 1994;6:917–924.
17.
Chen Y, Eggleston A, Tougas GH: Chronic lower gastrointestinal symptoms: Prevalence, sociodemographic factors and impact in the Canadian population: Findings from the DIGEST Study. Gastroenterology 2000;118:A395.
18.
Locke GR, Yawn BP, Wollan PC, Lydick E: Health services utilization in making the diagnosis of irritable bowel syndrome. Gastroenterology 1999;116:A1032.
19.
Talley NJ, Zinsmeister AR, von Dyke C, Melton NJ: Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927–934.
[PubMed]
20.
Russo MW, Gaynes BN, Drossman DA: A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 1999;29:339–343.
[PubMed]
https://doi.org/10.1097/00004836-199912000-00009
21.
Locke GR, Yawn BP, Wollan PC, Bertram S, Kurland M, Lydick E: The path to a diagnosis of irritable bowel syndrome: A population-based study. Gastroenterology 2000;118:A857.
22.
Hahn BA, Yan S, Strassels S: Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999;60:77–81.
[PubMed]
https://doi.org/10.1159/000007593
23.
Bentkover JD, Field C, Greene EM, Plourde V, Casciano JP: The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 1999;13(suppl A):89–96.
24.
Agreus L, Svaerdsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology 1995;109:671–680.
[PubMed]
25.
Oesterberg E, Blomquist L, Krakau I, Wenryb RM, Åsberg M, Hultcrantz R: A population-based study of irritable bowel syndrome and mental health. Scand J Gastroenterol 2000;35:264–268.
[PubMed]
https://doi.org/10.1080/003655200750024128
26.
Vatn MH, Mogstad TE, Gjone E: A study of patients with uncharacteristic abdominal disorders. Scand J Gastroenterol 1985;20:407–414.
[PubMed]
27.
Caballero Plasencia AM, Sofos Kontoyannis S, Valenzuela Barranco M, Martin Ruiz JL, Casado Caballero FJ, Guilarte López-Mañas J: Irritable bowel syndrome in patients with dyspepsia: A community-based study in southern Europe. Eur J Gastroenterol Hepatol 1999;11:517–522.
[PubMed]
28.
Capurso L, Gasbarrini G, Anti M, Bazzocchi G, Corazza GR, Koch M, Minoli G, Pallone F, Passaretti S, Scarpignato C: La gestione del paziente con sindrome dell’intestino irritabile in Italia. G Gastroenterol 1998;3:35–45.
29.
De Waal M, Donker G, van der Velde J: Spijsverteringsziekten onder de bevolking en in de huisartspraktijk. Utrecht, NIVEL, 1992.
30.
Donker GA, Foets M, Spreeuwenberg P: Patients with irritable bowel syndrome: Health status and use of health care services. Br J Gen Pract 1999,49:787–792.
31.
Guthrie E, Creed F, Dawson D, Tomenson B: A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991;100:450–457.
[PubMed]
32.
Müller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Nault B, Pecher EC, Rüegg PC, Lefkowitz MP: Tegaserod, a partial 5-HT4 receptor agonist, relieves key symptoms of irritable bowel syndrome. Gastroenterology 2000;118 (suppl 2):175.
33.
Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG: U.S. householder survey of functional gastrointestinal disorders. Dig Dis Sci 1993;38:1569–1580.
[PubMed]
© 2001 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2001
You do not currently have access to this content.